Found: 37
Select item for more details and to access through your institution.
Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
miR‐146a<sup>−/−</sup> mice model reveals that NF‐κB inhibition reverts inflammation‐driven myelofibrosis‐like phenotype.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1326, doi. 10.1002/ajh.27322
- By:
- Publication type:
- Article
The prognostic impact of non‐driver gene mutations and variant allele frequency in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 755, doi. 10.1002/ajh.27203
- By:
- Publication type:
- Article
Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 6, p. 423, doi. 10.2165/11599850-000000000-00000
- By:
- Publication type:
- Article
The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 371, doi. 10.1111/ejh.13561
- By:
- Publication type:
- Article
Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 4, p. 407, doi. 10.1111/ejh.12846
- By:
- Publication type:
- Article
Qualitative and Quantitative Comparison of Plasma Exosomes from Neonates and Adults.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1926, doi. 10.3390/ijms22041926
- By:
- Publication type:
- Article
Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1143, doi. 10.3390/ijms22031143
- By:
- Publication type:
- Article
Correction: Cuenca-Zamora, Ernesto José., et al. Tubulin in Platelets: When the Shape Matter. Int. J. Mol. Sci. 2019, 20, 3484.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Tubulin in Platelets: When the Shape Matters.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 14, p. 3484, doi. 10.3390/ijms20143484
- By:
- Publication type:
- Article
Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 2, p. 484, doi. 10.1177/1078155217735689
- By:
- Publication type:
- Article
Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia.
- Published in:
- Journal of Assisted Reproduction & Genetics, 2020, v. 37, n. 10, p. 2473, doi. 10.1007/s10815-020-01907-2
- By:
- Publication type:
- Article
Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 3, p. 285, doi. 10.1111/ejh.12588
- By:
- Publication type:
- Article
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2441, doi. 10.1002/cncr.34195
- By:
- Publication type:
- Article
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1605, doi. 10.1111/bjh.19403
- By:
- Publication type:
- Article
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 4, p. 529, doi. 10.1111/bjh.18440
- By:
- Publication type:
- Article
Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 988, doi. 10.1111/bjh.16988
- By:
- Publication type:
- Article
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 813, doi. 10.1111/bjh.13539
- By:
- Publication type:
- Article
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 786, doi. 10.1111/bjh.13886
- By:
- Publication type:
- Article
Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
- Published in:
- Neonatology (16617800), 2020, v. 117, n. 1, p. 15, doi. 10.1159/000504173
- By:
- Publication type:
- Article
Comprehensive comparison of neonate and adult human platelet transcriptomes.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183042
- By:
- Publication type:
- Article
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0181366
- By:
- Publication type:
- Article
Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1348, doi. 10.3390/cancers15041348
- By:
- Publication type:
- Article
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092331
- By:
- Publication type:
- Article
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 779, doi. 10.3390/jcm13030779
- By:
- Publication type:
- Article
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 20, p. 6217, doi. 10.3390/jcm11206217
- By:
- Publication type:
- Article
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 14, p. 3146, doi. 10.3390/jcm10143146
- By:
- Publication type:
- Article
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 737, doi. 10.1007/s00277-023-05610-x
- By:
- Publication type:
- Article
Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia.
- Published in:
- 2022
- By:
- Publication type:
- letter
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic risk models for transplant decision-making in myelofibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 6, p. 911, doi. 10.1007/s00277-015-2330-2
- By:
- Publication type:
- Article
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 12, p. 2037, doi. 10.1007/s00277-014-2152-7
- By:
- Publication type:
- Article
Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 6, p. 771, doi. 10.1007/s00277-013-1683-7
- By:
- Publication type:
- Article
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-68
- By:
- Publication type:
- Article